NO20073307L - Glycin gjenopptaksinhibitorer for behandling av medikament- og alkoholmisbruk - Google Patents
Glycin gjenopptaksinhibitorer for behandling av medikament- og alkoholmisbrukInfo
- Publication number
- NO20073307L NO20073307L NO20073307A NO20073307A NO20073307L NO 20073307 L NO20073307 L NO 20073307L NO 20073307 A NO20073307 A NO 20073307A NO 20073307 A NO20073307 A NO 20073307A NO 20073307 L NO20073307 L NO 20073307L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- treatment
- reuptake inhibitors
- alcohol abuse
- glycine reuptake
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000011117 substance-related disease Diseases 0.000 title abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title 2
- 206010013654 Drug abuse Diseases 0.000 title 1
- 239000004471 Glycine Substances 0.000 title 1
- 206010001584 alcohol abuse Diseases 0.000 title 1
- 208000025746 alcohol use disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 108010077895 Sarcosine Proteins 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Addiction (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100218 | 2005-01-14 | ||
| PCT/EP2006/050163 WO2006075011A2 (en) | 2005-01-14 | 2006-01-11 | Glycine reuptake inhibitors for treating drug and alcohol dependence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073307L true NO20073307L (no) | 2007-08-13 |
Family
ID=34938519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073307A NO20073307L (no) | 2005-01-14 | 2007-06-28 | Glycin gjenopptaksinhibitorer for behandling av medikament- og alkoholmisbruk |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080051456A1 (ja) |
| EP (1) | EP1841418B1 (ja) |
| JP (1) | JP5123669B2 (ja) |
| KR (1) | KR20070104597A (ja) |
| CN (1) | CN101102759A (ja) |
| AU (1) | AU2006205796B2 (ja) |
| CA (1) | CA2593274C (ja) |
| IL (1) | IL184236A0 (ja) |
| MX (1) | MX2007008460A (ja) |
| NO (1) | NO20073307L (ja) |
| NZ (1) | NZ556467A (ja) |
| RU (1) | RU2007130941A (ja) |
| WO (1) | WO2006075011A2 (ja) |
| ZA (1) | ZA200705668B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011502974A (ja) * | 2007-11-06 | 2011-01-27 | ナームローゼ・フエンノートチヤツプ・オルガノン | ヒトにおけるホルモン抑制の方法 |
| CN104621437A (zh) * | 2015-01-21 | 2015-05-20 | 胡家宁 | 一种用于抵抗酒精依赖的食品 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311804D0 (en) * | 1983-04-29 | 1983-06-02 | Merrell Toraude & Co | Treatment of seizure disorders and pharmaceutical compositions |
| TW555757B (en) * | 1998-07-31 | 2003-10-01 | Akzo Nobel Nv | Aminomethylcarboxylic acid derivatives |
| DE10149370A1 (de) * | 2001-10-06 | 2003-04-10 | Merck Patent Gmbh | Pyrazolderivate |
| FR2842804B1 (fr) * | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2842805A1 (fr) * | 2002-07-29 | 2004-01-30 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide,leur preparation et leur application et therapeutique |
| WO2004080454A1 (en) * | 2003-03-14 | 2004-09-23 | Andries Petrus Burger | Composition comprising 5-hydroxytryptophan for reducing or alleviating the effects of nicotine withdrawal and use thereof |
-
2006
- 2006-01-11 CN CNA2006800023149A patent/CN101102759A/zh active Pending
- 2006-01-11 AU AU2006205796A patent/AU2006205796B2/en active Active
- 2006-01-11 WO PCT/EP2006/050163 patent/WO2006075011A2/en active Application Filing
- 2006-01-11 US US11/813,894 patent/US20080051456A1/en not_active Abandoned
- 2006-01-11 CA CA2593274A patent/CA2593274C/en active Active
- 2006-01-11 JP JP2007550790A patent/JP5123669B2/ja active Active
- 2006-01-11 EP EP06707702.4A patent/EP1841418B1/en active Active
- 2006-01-11 RU RU2007130941/14A patent/RU2007130941A/ru not_active Application Discontinuation
- 2006-01-11 NZ NZ556467A patent/NZ556467A/en not_active IP Right Cessation
- 2006-01-11 KR KR1020077018569A patent/KR20070104597A/ko not_active Application Discontinuation
- 2006-01-11 MX MX2007008460A patent/MX2007008460A/es not_active Application Discontinuation
-
2007
- 2007-06-26 IL IL184236A patent/IL184236A0/en unknown
- 2007-06-28 NO NO20073307A patent/NO20073307L/no not_active Application Discontinuation
- 2007-07-10 ZA ZA200705668A patent/ZA200705668B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL184236A0 (en) | 2007-10-31 |
| WO2006075011A2 (en) | 2006-07-20 |
| EP1841418B1 (en) | 2013-04-17 |
| CN101102759A (zh) | 2008-01-09 |
| MX2007008460A (es) | 2007-07-25 |
| WO2006075011A3 (en) | 2006-11-23 |
| RU2007130941A (ru) | 2009-02-20 |
| KR20070104597A (ko) | 2007-10-26 |
| CA2593274C (en) | 2013-10-29 |
| EP1841418A2 (en) | 2007-10-10 |
| US20080051456A1 (en) | 2008-02-28 |
| ZA200705668B (en) | 2008-07-30 |
| NZ556467A (en) | 2009-09-25 |
| JP2008526924A (ja) | 2008-07-24 |
| AU2006205796A1 (en) | 2006-07-20 |
| JP5123669B2 (ja) | 2013-01-23 |
| AU2006205796B2 (en) | 2010-09-02 |
| CA2593274A1 (en) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0112666A (pt) | Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c | |
| NO20084256L (no) | DPP IV inhibitorformuleringer | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| BR0306931A (pt) | Peptìdeos como inibidores de protease serina-ns3 do vìrus da hepatite c | |
| CY1109523T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv | |
| ECSP17000643A (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol. | |
| WO2005002627A3 (en) | Conjugated complement cascade inhibitors | |
| RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
| TW200732351A (en) | New cyclic peptide compounds | |
| MX2009011512A (es) | Nuevos compuestos peptidos ciclicos. | |
| WO2008042480A3 (en) | Epoxide inhibitors of cysteine proteases | |
| SE0002202D0 (sv) | New peptides | |
| DK1456380T3 (da) | SMAD7-inhibitorer til behandling af CNS-sygdomme | |
| WO2007006732A8 (en) | Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) | |
| DK1656131T3 (da) | Anvendelse af betain til behandling claudicatio intermittens | |
| NO20073307L (no) | Glycin gjenopptaksinhibitorer for behandling av medikament- og alkoholmisbruk | |
| WO2005002500A3 (en) | Inhibitors of coronavirus | |
| BRPI0514021A (pt) | métodos para aperfeiçoamento de biodisponibilidade de um inibidor de renina | |
| WO2009041786A3 (en) | Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper longum for the prevention and treatment of inflammatory disease | |
| TW200700075A (en) | Roflumilast and integrin inhibitor combination and method of treatment | |
| ATE502637T1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| ATE469168T1 (de) | Peptide zur transglutaminase-hemmung | |
| NO20064645L (no) | Kombinasjoner av deramiciclan og opioider som smertestillende midler | |
| MXPA06002778A (es) | Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. | |
| NO20072851L (no) | Hoydose forlenget frigivelses formulering av gepiron |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |